Advertisement

Molecular and Cellular Biochemistry

, Volume 361, Issue 1–2, pp 289–296 | Cite as

Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro

  • Savita Bansal
  • Manushi Siddarth
  • Diwesh Chawla
  • Basu D. Banerjee
  • S. V. Madhu
  • Ashok K. Tripathi
Article

Abstract

Increased oxidative stress (OS) in diabetes mellitus is one of the major factors leading to diabetic pathology. However, the mediators and mechanism that provoke OS in diabetes is not fully understood, and it is possible that accumulation of advanced glycation end products (AGEs) formed secondary to hyperglycemic conditions may incite circulating polymorphonuclear neutrophils (PMN) to generate reactive oxygen species (ROS). In this report, we aim to investigate the effect of AGE on reactive oxygen and nitrogen species generation and subsequent OS in PMN. AGE-HSA exert dose- and time-dependent enhancement of ROS and reactive nitrogen intermediates (RNI) generation by PMN. Increased ROS and RNI generation were found to be mediated through the upregulation of NADPH oxidase and inducible nitric oxide synthase (iNOS), respectively, as evident from the fact that AGE-treated neutrophils failed to generate ROS and RNI in presence of diphenyleneiodonium, a flavoprotein inhibitor for both enzymes. Further increased generation of ROS and RNI ceased when the cells were incubated with anti-RAGE antibody suggesting the involvement of AGE–RAGE interaction. Also increased malondialdehyde (MDA) and protein carbonyl formation in AGE-exposed PMN suggest induction of OS by AGE. This study provides evidence that AGEs may play a key role in the induction of oxidative stress through the augmentation of PMN-mediated ROS and RNI generation and this may be in part responsible for development of AGE-induced diabetic pathology.

Keywords

Advanced glycation end products Polymorphonuclear neutrophil NADPH oxidase Inducible nitric oxide synthase Protein carbonyl Malondialdehyde Diphenyleneiodonium Reactive oxygen and nitrogen species 

Notes

Acknowledgment

This work is supported through a project funded by Indian Council of Medical research and one of the authors Savita Bansal is thankful to Council of Scientific and Industrial Research (CSIR), New Delhi, India for providing Junior Research Fellowship (NET). Authors are thankful to Prof. Rina Chakrabarti, Department of Zoology, University of Delhi and Dr. Sudip Dutta for providing necessary help in spectrofluorometric assays and manuscript editing, respectively.

References

  1. 1.
    Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820PubMedCrossRefGoogle Scholar
  2. 2.
    Sharp PS, Rainbow S, Mukherjee S (2003) Serum levels of low molecular weight advanced glycation end products in diabetic subjects. Diabet Med 20:575–579PubMedCrossRefGoogle Scholar
  3. 3.
    John WG, Lamb EJ (1993) The Maillard or browning reaction in diabetes. Eye 7:230–237PubMedCrossRefGoogle Scholar
  4. 4.
    Lapolla A, Piarulli F, Sartore G et al (2007) Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. Diabetes Care 30:670–676PubMedCrossRefGoogle Scholar
  5. 5.
    Piwowar A, Knapik-Krdecka M, Szczecinska J, Warwas M (2008) Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Diabetes Metab Res Rev 24:549–553PubMedCrossRefGoogle Scholar
  6. 6.
    Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 287:2570–2581PubMedCrossRefGoogle Scholar
  7. 7.
    Nin JW, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD (2011) Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes. Diabetes Care 34:442–447PubMedCrossRefGoogle Scholar
  8. 8.
    Goh SY, Cooper ME (2008) The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93:1143–1152PubMedCrossRefGoogle Scholar
  9. 9.
    Wada R, Yagihashi S (2005) Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann NY AcadSci 1043:598–604CrossRefGoogle Scholar
  10. 10.
    Al-Mesallamy HO, Hammad LN, El-Mamoun TA, Khalil BM (2011) Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy. J Diabetes Complicat 25(3):168–174PubMedCrossRefGoogle Scholar
  11. 11.
    Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JEB (2006) Diabetes and advanced glycation end products. Diabetes Care 29(6):1420–1429PubMedCrossRefGoogle Scholar
  12. 12.
    Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, Perego C, Muscogiuri G (2011) The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. (Epub ahead of print)Google Scholar
  13. 13.
    Pitocco D, Zaccardi F, Stasio ED, Romitelli F, Santini SA, Zuppi C, Ghirlanda G (2010) Oxidative stress, nitric oxide, and diabetes. Rev Diabetes Stud 7:15–25CrossRefGoogle Scholar
  14. 14.
    Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam BH, Malabanan A, Trackman PC, Badwey JA, Van Dyke TE (2005) Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol 78:862–870PubMedCrossRefGoogle Scholar
  15. 15.
    Hand WL, Hand DL, Vasquez Y (2007) Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. Diabetes Res Clin Pract 76:44–50PubMedCrossRefGoogle Scholar
  16. 16.
    Gupta A, Tripathi AK, Tripathi RL, Madhu SV, Banerjee BD (2007) Advanced glycosylated end products mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress. Indian J Biochem Biophys 44:373–378PubMedGoogle Scholar
  17. 17.
    Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, Hammami MM, Schmidt AM, Stern DM, Al-Mohanna FA, Kate S (2002) RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol 71:433–444PubMedGoogle Scholar
  18. 18.
    Takeuchi M, Yanase Y, Matsuura N, Yamagishi S, Kameda Y, Bucala R, Makita Z (2001) Immunological detection of a novel advanced glycation end products. Mol Med 7(11):783–791PubMedGoogle Scholar
  19. 19.
    Habeeb AFSA (1996) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14:328CrossRefGoogle Scholar
  20. 20.
    Kalousová M, Krha J, Zima T (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51:597–604PubMedGoogle Scholar
  21. 21.
    Baron DN, Ahmed SA (1969) Intracellular concentrations of water and of the principal electrolytes determined by analysis of isolated human leucocytes. Clin Sci 37:205–219PubMedGoogle Scholar
  22. 22.
    Pick E (1986) Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol 132:407–421PubMedCrossRefGoogle Scholar
  23. 23.
    Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen, intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 141:2407–2411PubMedGoogle Scholar
  24. 24.
    Aydemir B, Onaran I, Kiziler AR, Alici B et al (2007) Increased oxidative damage of sperm and seminal plasma in men with idiopathic infertility is higher in patients with glutathione S-transferase Mu-1 null genotype. Asian J Androl 9:108–115PubMedCrossRefGoogle Scholar
  25. 25.
    Girotti MJ, Khan N, Mclellan BA (1991) Early measurement of systemic lipid peroxidation products in the plasma of major blunt trauma patients. J Trauma-Inj Infect Crit Care 31(1):32–35CrossRefGoogle Scholar
  26. 26.
    Wong RKM, Pettit AI, Quinn PA, Jennings SC, Davies JE, Leong L Ng (2003) Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid. Circulation 108:1858–1864PubMedCrossRefGoogle Scholar
  27. 27.
    Ding Y, Kantarci A, Hasturk H, Trackman PC, Malabanan A, Van Dyke TE (2007) Activation of RAGE induces elevated O2− generation by mononuclear phagocytes in diabetes. J Leukoc Biol 81(2):520–527PubMedCrossRefGoogle Scholar
  28. 28.
    Zhang FL, Gao HQ, Shen L (2007) Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells. J Cardiovasc Pharmacol 50:434–440PubMedCrossRefGoogle Scholar
  29. 29.
    Ayilavarapu S, Kantarci A, Fredman G, Turkoglu O, Omoril K, Liu H, Iwata T, Yagi M, Hasturk H, Van Dyke TE (2010) Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils. J Immunol 184(3):1507–1515PubMedCrossRefGoogle Scholar
  30. 30.
    Chang PC, Chen TH, Chang CJ, Hou CC, Chan P, Lee HM (2004) Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway. Kidney Int 65:1664–1675PubMedCrossRefGoogle Scholar
  31. 31.
    Rojas A, Caveda L, Romay C et al (1996) Effects of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages. Biochem Biophys Res Commun 225:358–362PubMedCrossRefGoogle Scholar
  32. 32.
    Amore A, Cirina P, Mitola S et al (1997) Non-enzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int 51:27–35PubMedCrossRefGoogle Scholar
  33. 33.
    Lin CH, Lin YF, Chang MC et al (2001) Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: involvement of a p38 MAP kinase-dependent mechanism. Life Sci 69:2503–2515PubMedCrossRefGoogle Scholar
  34. 34.
    Bechman JS, Beckman TV, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620–1624CrossRefGoogle Scholar
  35. 35.
    Pan HZ, Zhang H, Chang D et al (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551PubMedCrossRefGoogle Scholar
  36. 36.
    Datta SK, Kumar V, Pathak R, Tripathi AK, Ahmed RS, Kalra OP, Banerjee BD (2010) Association of glutathione S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and non-diabetic chronic kidney disease. Ren Fail 32(10):1189–1195PubMedCrossRefGoogle Scholar
  37. 37.
    Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R, Nathan CF (1991) Inhibition of macrophage and endothelial nitric oxide synthase by DPI and its analogs. FASEB J 5:98–103PubMedGoogle Scholar
  38. 38.
    O’Donnell BV, Tew DG, Jones OT, England PJ (1993) Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 290:41–49PubMedGoogle Scholar
  39. 39.
    Toure F, Zahm JM, Garnotel R, Lambert E, Bonnet N, Schmidt AM, Vitry F, Chanard J, Gillery P, Rieu P (2008) Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem J 416:255–261PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2011

Authors and Affiliations

  • Savita Bansal
    • 1
  • Manushi Siddarth
    • 1
  • Diwesh Chawla
    • 1
  • Basu D. Banerjee
    • 1
  • S. V. Madhu
    • 2
  • Ashok K. Tripathi
    • 1
  1. 1.Biochemistry and Immunology Laboratory, Department of BiochemistryUniversity College of Medical Sciences (University of Delhi) and G.T.B. HospitalDelhiIndia
  2. 2.Department of MedicineUniversity College of Medical Sciences (University of Delhi) and G.T.B. HospitalDelhiIndia

Personalised recommendations